Chronic inflammation is a harmful and long-lasting immune response that can lead to severe health problems like Alzheimer’s, Parkinson’s, diabetes, and cancer.
Unlike the short-term inflammation that helps the body heal from injuries or infections, chronic inflammation occurs when the immune system stays active for too long.
This overreaction, often triggered by aging, stress, or exposure to environmental toxins, damages the body over time.
In a groundbreaking study, scientists at the University of California, Berkeley, have identified a molecular “switch” that could help control the immune system’s role in chronic inflammation.
This discovery provides hope for new treatments that could prevent or even reverse many age-related diseases. The study, led by Danica Chen and published in Cell Metabolism, focuses on a key group of immune proteins called the NLRP3 inflammasome.
The NLRP3 inflammasome acts like a security guard in the body, detecting potential threats and triggering inflammation to fight off infections or repair injuries.
However, when this inflammasome becomes overactive, it can cause harmful chronic inflammation, contributing to diseases such as multiple sclerosis, diabetes, cancer, and dementia.
The researchers found that the NLRP3 inflammasome can be turned off through a process called deacetylation. In this process, a small molecular fragment is removed, effectively deactivating the inflammasome and stopping unnecessary inflammation.
A protein called SIRT2 is responsible for this deactivation. By removing the fragment, SIRT2 acts as a natural “off switch” for the inflammasome, protecting the body from harm.
To explore the effects of this process, the researchers conducted experiments on mice. They found that mice lacking SIRT2 showed increased inflammation as they aged.
By the time these mice were two years old, they exhibited more severe inflammation and higher levels of insulin resistance, which is often a precursor to diabetes and other metabolic problems.
In another experiment, older mice had their immune systems reset with radiation and rebuilt using blood stem cells. These stem cells were designed to produce either an active or inactive form of the NLRP3 inflammasome.
The mice with the inactive (deacetylated) version showed significant improvements in insulin resistance after six weeks, suggesting that turning off the inflammasome might not only prevent inflammation but also reverse certain diseases.
This discovery has far-reaching implications. If drugs can be developed to target this deacetylation process, it could lead to new therapies for chronic diseases like diabetes, Alzheimer’s, and cancer.
Early intervention might even prevent these conditions from developing in the first place. For diseases like Alzheimer’s, where treatments often fail because they start too late, targeting chronic inflammation early could halt or reverse the progression of damage.
The study also reinforces the importance of managing inflammation for long-term health. Chronic inflammation is linked to lifestyle factors such as diet, stress, and exposure to toxins.
Other studies have highlighted how some diets may harm bone health, how compounds in cannabis could protect the brain, and how certain food oils might negatively affect brain genes. These findings emphasize the complex relationship between inflammation, diet, and disease.
This new research is a significant step toward understanding and controlling chronic inflammation, offering hope for healthier, longer lives.
By addressing the root causes of inflammation, scientists aim to develop treatments that go beyond managing symptoms, potentially transforming how we age and fight disease.
If you care about inflammation, please read studies about the big cause of inflammation in common bowel disease, and vitamin B may help fight COVID-19 and reduce inflammation.
For more health information, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.
Copyright © 2024 Knowridge Science Report. All rights reserved.
